The Rare Disease Company Coalition

The Rare Disease Company Coalition is dedicated to advancing the discovery, development, and delivery of treatments for rare diseases, focusing on improving patient outcomes and addressing unmet medical needs. As a leading advocate in the pharmaceutical manufacturing sector, The Rare Disease Company Coalition is committed to informing policymakers about the unique challenges and opportunities within rare disease drug development and manufacturing.

Located in Washington, DC, 20004, US, The Rare Disease Company Coalition plays a crucial role in fostering collaboration among life science companies. By uniting industry expertise, The Rare Disease Company Coalition aims to drive innovation and accelerate the availability of life-changing therapies for individuals affected by rare diseases.

The Rare Disease Company Coalition continuously strives to enhance the ecosystem for rare disease research and treatment. We invite the manager of The Rare Disease Company Coalition to create a customized and exclusive company showcase and product listing on our platform, further amplifying their reach and impact in the pharmaceutical industry.